mounjaro and retatrutide vs (UK): the simple, evidence‑based guide Retatrutide (“reta”) is an experimental

Taking GLP-1 agonists without behavior and lifestyle modification can actually lead to worse metabolic health due to both a loss of muscle mass and nutrient deficiencies

Both treatments require consistent use for noticeable results

placebo, -1.55 vs

Food and Drug Administration, Understanding Investigational Drugs , April 2, 2019 GoodRx, Retatrutide for Weight Loss: Availability, Dosage, and More , June 25, 2026 Food and Drug Administration, Expanded Access, accessed June 29, 2026 Eli Lilly, Expanded Access | Compassionate Use | Clinical Trials , accessed June 29, 2026 WBUR | Here & Now, An extraordinary new obesity drug is still awaiting FDA approval

ABC News

For these agents to act on posterior segment tissues, they must traverse the formidable BRB, which significantly restricts drug penetration